Tags

Type your tag names separated by a space and hit enter

Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
Bioorg Med Chem Lett. 2008 Jul 15; 18(14):3942-5.BM

Abstract

We have previously described poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors based on a substituted benzyl-phthalazinone scaffold. As an alternative chemical template, a novel series of alkoxybenzamides were developed with restricted conformation through intramolecular hydrogen bond formation; the compounds exhibit low nM enzyme and cellular activity as PARP-1 inhibitors.

Authors+Show Affiliations

KuDOS Pharmaceuticals Ltd, 410 Cambridge Science Park, Milton Road, Cambridge CB4 0PE, UK. kmenear@kudospharma.co.ukNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18579376

Citation

Menear, Keith A., et al. "Novel Alkoxybenzamide Inhibitors of poly(ADP-ribose) Polymerase." Bioorganic & Medicinal Chemistry Letters, vol. 18, no. 14, 2008, pp. 3942-5.
Menear KA, Adcock C, Alonso FC, et al. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorg Med Chem Lett. 2008;18(14):3942-5.
Menear, K. A., Adcock, C., Alonso, F. C., Blackburn, K., Copsey, L., Drzewiecki, J., Fundo, A., Le Gall, A., Gomez, S., Javaid, H., Lence, C. F., Martin, N. M., Mydlowski, C., & Smith, G. C. (2008). Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters, 18(14), 3942-5. https://doi.org/10.1016/j.bmcl.2008.06.025
Menear KA, et al. Novel Alkoxybenzamide Inhibitors of poly(ADP-ribose) Polymerase. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3942-5. PubMed PMID: 18579376.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. AU - Menear,Keith A, AU - Adcock,Claire, AU - Alonso,Francisco Cuenca, AU - Blackburn,Kristel, AU - Copsey,Louise, AU - Drzewiecki,Jan, AU - Fundo,Alexandra, AU - Le Gall,Armelle, AU - Gomez,Sylvie, AU - Javaid,Hashim, AU - Lence,Carlos Fenandez, AU - Martin,Niall M B, AU - Mydlowski,Chris, AU - Smith,Graeme C M, Y1 - 2008/06/12/ PY - 2008/02/06/received PY - 2008/06/06/revised PY - 2008/06/06/accepted PY - 2008/6/27/pubmed PY - 2008/11/18/medline PY - 2008/6/27/entrez SP - 3942 EP - 5 JF - Bioorganic & medicinal chemistry letters JO - Bioorg Med Chem Lett VL - 18 IS - 14 N2 - We have previously described poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors based on a substituted benzyl-phthalazinone scaffold. As an alternative chemical template, a novel series of alkoxybenzamides were developed with restricted conformation through intramolecular hydrogen bond formation; the compounds exhibit low nM enzyme and cellular activity as PARP-1 inhibitors. SN - 1464-3405 UR - https://www.unboundmedicine.com/medline/citation/18579376/Novel_alkoxybenzamide_inhibitors_of_poly_ADP_ribose__polymerase_ DB - PRIME DP - Unbound Medicine ER -